ZeroStack Corp. (ZSTK)
NCM · Asset Management
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Peers in Asset Management
All in industry →BlackRock, Inc.
Blackstone Inc.
Brookfield Corporation
KKR & Co. Inc.
Brookfield Asset Management Ltd.
Apollo Global Management, Inc.
Ameriprise Financial, Inc.
State Street Corporation
Ares Management Corporation
Raymond James Financial, Inc.
Recent press releases
ZeroStack Corp. has not issued a press release in this window.
SEC filings
All filings →ZeroStack Corp. has not filed an SEC document in this window.
Insider trades
All insider trades →ZeroStack Corp. has no reported insider trades in the last 90 days.
Institutional holders
All holders →No 13F holdings have been reported for ZeroStack Corp. in this window.
People at ZeroStack Corp.
All people →No officers or directors have been indexed for ZeroStack Corp..